Home / Pharmaceuticals / Immunocytokines Market By Diagnostic Test (PAP Tests, HPV Tests, Biopsy, Colposcopy, Cystoscopy ) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

Immunocytokines Market By Diagnostic Test (PAP Tests, HPV Tests, Biopsy, Colposcopy, Cystoscopy ) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

Published: Dec 2018 | Report Code: 59481-12-18

Immunocytokines market to exhibit profitable growth during the forecast period

The global immunocytokines market is growing significantly. In recent years monoclonal antibodies are being utilized to treat a wide array of cancer-related diseases. These monoclonal antibodies are mainly mono-specific encompassing similar immune cells which are copies of a single parent cell and are concentrated towards a definite cellular target. These antibodies due to its customizable environment, it can be used to only treat the tumor cells ineffective of the normal ones in the living body.  However, a huge number of immunocytokines in the pipeline, high prevalence with no or less medical efficiency in developing nations, less awareness, the high cost of treatment, inflexible government regulations towards cancer diagnosis are factors restraining the development of immunocytokines market globally.

Market Synopsis

Immunocytokines Market

Tumors and cancer segment is expected to register higher growth in the developing nations by the end of 2026

An increasing prevalence of cancer along with along with new technological assessment in genetic sequencing and target gene selection are factors driving the overall growth of the global immunocytokines market. Few human cytokines such as IL2 have been approved (Proleukin) for diseases such as metastatic renal cell carcinoma and metastatic melanoma. Chemotherapy and drugs are used to treat cancer. Various adverse side effects that comes with the medication has made the pharmaceutical organizations to concentrate on monoclonal antibodies along with immunocytokines. According to WHO, cancer is a leading cause of mortality on a global scale, in 2018, an estimated 9.8 million individuals passed away due to cancer. Majority of them were diagnosed with lung and breast cancer.

Immunocytokines Market

Lung targeting site segment is expected to register higher growth in the developing nations by the end of 2026

Advancement in antibody-based delivery of IL2 and cytotoxics has shown promising results in recent years. As per WHO in 2018, more than 2.08 million cases were registered due to lung cancer globally. More than 11 types of immunocytokines are still in pipeline (phase I/II). They have been developed against various, tumor-associated antigens such as epithelial, cell-adhesion molecule, carbonic anhydrase 9, fibroblast activation protein, epidermal growth factor receptor, fibronectin splice variants, and, tenascin splice variants. For instance, scientists from Philogen (Italy) have developed immunocytokines based on IL2, IL12, IL4, IL10 and TNF, which are presently being inspected in pre-clinical studies. Increasing geriatric population, government or private funding for cancer research, and changing lifestyles resulting in chronic disorders are factors driving the growth of immunocytokines market.

Immunocytokines Market

Increasing prevalence of cervical cancer along with advanced diagnostic procedures is gaining traction in developing economies

North America spearheaded the market in 2017 owing to the presence of top pharmaceutical and research organizations along with increasing incidences for breast and lung cancer in the U.S., as indicated by a report published by American Cancer Society, in 2018, more than 1.6 million new cancer cases were diagnosed and around 600,000 deaths were registered. In recent years, top biotechnology and pharmaceutical companies in the U.S. and Europe have started investing in monoclonal antibodies.  The driving factors include, heavy investment in R&D, approval for antibody-based molecules (more than 70), huge number of medications in pipeline and advancement in conjugated cancer therapies worldwide.

Immunocytokines Market

High prevalence of cancer, less availability of medications and treatment in the developing nations

Major players in the immunocytokines market are Alkermes Plc, AstraZeneca Plc, CytImmune, Cytune Pharma, Altor Biosciences Corporation, Apeiron Biologics AG, Paladin Labs, Teva Pharmaceutical Industries Ltd., Valor Biotherapeutics, Targa Therapeutics Corporation, Immunomedics, Inc., ImmunGene, Inc., MolMed S.p.A., Merck KGaA, Nektar Therapeutics, Pfizer, Inc., F. Hoffmann-La Roche, Ltd. and others. These companies are employing growth strategies along with new approvals for medications related to cancer.

Immunocytokines Market

Historical & Forecast Period

2016 – Historical Year

2017 – Base Year

2018 - 2026 – Forecast Period

This study report represents analysis for each segment from 2016 to 2026 considering 2017 to be the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period from 2018 to 2026.

Report Scope by Segments

Immunocytokines Market

Immunocytokines market comprises current market trends and dynamics along with quantitative analysis of the global market. The report elucidates thorough information of global immunocytokines market by segmenting the market in terms of product, modality, end-use, and geography. This report would guide healthcare professionals and market players in decision-making and strategizing market position.

Disease Indication Segment (2016–2026; US$ Mn)

  • Tumors and Cancer
  • Rheumatoid Arthritis

Targeting Site Segment (2016–2026; US$ Mn)

  • Liver
  • Hypothalamus
  • Fat muscle
  • B and T lymphocytes 
  • Bone Marrow Endothelium

Geography Segment (2016–2026; US$ Mn)

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • Rest of Middle East & Africa

The current report also comprehends qualitative market assessment factors such as market trends, key market drivers, restraints and opportunities that gives a better market understanding of the overall immunocytokines market. Furthermore, the report also comprises graphical representation of competitive landscape based on their market initiatives and strategies, product portfolio and business strengths.

Key questions answered in this report

  • What are the current market trends and dynamics in the immunocytokines market and valuable opportunities for emerging players?
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which end-user holds a larger market share and why?
  • What is the market trend and dynamics in emerging markets such as Japan, Latin America and Middle East & Africa?

Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global Cervical Cancer Diagnostic Test Market Portraiture
2.2. Global Cervical Cancer Diagnostic Test Market, By Diagnostic Test Type, 2017 (US$ Mn)
2.3. Global Cervical Cancer Diagnostic Test Market, by Geography, 2017 Vs 2026 (Value %)

Chapter 3. Global Cervical Cancer Diagnostic Test Market: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Cervical Cancer Diagnostic Test: Future Trends
3.3. Current Scenario: Strategies Used for Drug Delivery Across BBB Drivers
3.4. Challenges
3.5. Opportunities
3.6. Attractive Investment Proposition, by Geography, 2017
3.7. Major Agreements, Partnerships and Collaborations
3.8. Competitive Landscape
3.8.1. Competitive Landscape, by Key Players, 2017

Chapter 4. Global Cervical Cancer Diagnostic Test Market, by Diagnostic Test Type, 2016 – 2026 (US$ Mn)
4.1. Overview
4.2. PAP Tests
4.3. HPV Tests
4.4. Biopsy
4.4.1. Cone biopsy
4.4.2. Endocervical Curettage
4.4.3. Punch biopsy & Others
4.5. Colposcopy
4.6. Cystoscopy

Chapter 5. Global Cervical Cancer Diagnostic Test Market, by Geography, 2016 – 2026 (US$ Mn)
5.1. Overview
5.2. North America Cervical Cancer Diagnostic Test Market Analysis, 2016 – 2026
5.2.1. North America Cervical Cancer Diagnostic Test Market, By Diagnostic Test Type, 2016 – 2026 (US$ Mn)
5.2.2. North America Cervical Cancer Diagnostic Test Market, by Country, 2016 – 2026 (US$ Mn)
5.2.2.1. U.S.
5.2.2.2. Canada
5.3. Europe Cervical Cancer Diagnostic Test Market Analysis, 2016 – 2026
5.3.1. Europe Cervical Cancer Diagnostic Test Market, By Diagnostic Test Type, 2016 – 2026 (US$ Mn)
5.3.2. Europe Cervical Cancer Diagnostic Test Market, by Country, 2016 – 2026 (US$ Mn)
5.3.2.1. U.K.
5.3.2.2. Germany
5.3.2.3. Rest of Europe
5.4. Asia Pacific Cervical Cancer Diagnostic Test Market Analysis, 2016 – 2026
5.4.1. Asia Pacific Cervical Cancer Diagnostic Test Market, By Diagnostic Test Type, 2016 – 2026 (US$ Mn)
5.4.2. Asia Pacific Cervical Cancer Diagnostic Test Market, by Country, 2016 – 2026 (US$ Mn)
5.4.2.1. Japan
5.4.2.2. China
5.4.2.3. Rest of APAC
5.5. Latin America Cervical Cancer Diagnostic Test Market Analysis, 2016 – 2026
5.5.1. Latin America Cervical Cancer Diagnostic Test Market, By Diagnostic Test Type, 2016 – 2026 (US$ Mn)
5.5.2. Latin America Cervical Cancer Diagnostic Test Market, by Country, 2016 – 2026 (US$ Mn)
5.5.2.1. Brazil
5.5.2.2. Mexico
5.5.2.3. Rest of Latin America
5.6. Middle East & Africa (MEA) Cervical Cancer Diagnostic Test Market Analysis, 2016 – 2026
5.6.1. MEA Cervical Cancer Diagnostic Test Market, by Diagnostic Test Type, 2016 – 2026 (US$ Mn)
5.6.2. MEA Cervical Cancer Diagnostic Test Market, by Region, 2016 – 2026 (US$ Mn)
5.6.2.1. GCC
5.6.2.2. Rest of MEA

Chapter 6. Company Profiles
6.1. Hologic Corporation
6.1.1. Business Description
6.1.2. Financial Information (Subject to data availability)
6.1.3. Product Portfolio
6.1.4. Key Developments
6.2. Becton, Dickinson and Company
6.3. Qiagen N.V.
6.4. Siemens Healthcare
6.5. Guided Therapeutics, Inc.
6.6. Ascon Medical Instruments Pvt Ltd
6.7. Hoffmann-La Roche
6.8. Cooper Surgical Inc.
6.9. Cardinal Health, Inc.
6.10. Beckman Coulter Inc.

FIG. 1 Global Cervical Cancer Diagnostic Test Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Cervical Cancer Diagnostic Test Market Segmentation
FIG. 4 Global Cervical Cancer Diagnostic Test Market, by Diagnostic Test Type, 2017 (US$ Mn)
FIG. 5 Global Cervical Cancer Diagnostic Test Market, by Geography, 2017 (US$ Mn)
FIG. 6 Attractive Investment Proposition, by Geography, 2017
FIG. 7 Global Market Positioning of Key Cervical Cancer Diagnostic Test Manufacturers, 2017
FIG. 8 Global Pap Test Market for Cervical Cancer Diagnostic Test, 2016–2026 (US$ Mn)
FIG. 9 Global HPV Test Market for Cervical Cancer Diagnostic Test, 2016–2026 (US$ Mn)
FIG. 10 Global Biopsy Test Market for Cervical Cancer Diagnostic Test, 2016–2026 (US$ Mn)
FIG. 11 Global Colposcopy Market for Cervical Cancer Diagnostic Test, 2016–2026 (US$ Mn)
FIG. 12 Global Cystoscopy Market for Cervical Cancer Diagnostic Test, 2016–2026 (US$ Mn)
FIG. 13 U.S. Cervical Cancer Diagnostic Test Market, 2016–2026 (US$ Mn)
FIG. 14 Canada Cervical Cancer Diagnostic Test Market, 2016–2026 (US$ Mn)
FIG. 15 U.K. Cervical Cancer Diagnostic Test Market, 2016–2026 (US$ Mn)
FIG. 16 Germany Cervical Cancer Diagnostic Test Market, 2016–2026 (US$ Mn)
FIG. 17 Rest of Europe Cervical Cancer Diagnostic Test Market, 2016–2026 (US$ Mn)
FIG. 18 Japan Cervical Cancer Diagnostic Test Market, 2016–2026 (US$ Mn)
FIG. 19 China Cervical Cancer Diagnostic Test Market, 2016–2026 (US$ Mn)
FIG. 20 Rest of Asia Pacific Cervical Cancer Diagnostic Test Market, 2016–2026 (US$ Mn)
FIG. 21 Brazil Cervical Cancer Diagnostic Test Market, 2016–2026 (US$ Mn)
FIG. 22 Mexico Cervical Cancer Diagnostic Test Market, 2016–2026 (US$ Mn)
FIG. 23 Rest of Latin America Cervical Cancer Diagnostic Test Market, 2016–2026 (US$ Mn)
FIG. 24 GCC Cervical Cancer Diagnostic Test Market, 2016–2026 (US$ Mn)
FIG. 25 Rest of Middle East & Africa Cervical Cancer Diagnostic Test Market, 2016–2026 (US$ Mn)

TABLE 1 Market Snapshot: Global Cervical Cancer Diagnostic Test Market
TABLE 2 Global Cervical Cancer Diagnostic Test Market, by Diagnostic Test Type, 2016–2026 (US$ Mn)
TABLE 3 Global Cervical Cancer Diagnostic Test Market, by Geography, 2016–2026 (US$ Mn)
TABLE 4 North America Cervical Cancer Diagnostic Test Market, by Diagnostic Test Type, 2016–2026 (US$ Mn)
TABLE 5 North America Cervical Cancer Diagnostic Test Market, by Country, 2016–2026 (US$ Mn)
TABLE 6 Europe Cervical Cancer Diagnostic Test Market, by Diagnostic Test Type, 2016–2026 (US$ Mn)
TABLE 7 Europe Cervical Cancer Diagnostic Test Market, by Country/Region, 2016–2026 (US$ Mn)
TABLE 8 Latin America Cervical Cancer Diagnostic Test Market, by Diagnostic Test Type, 2016–2026 (US$ Mn)
TABLE 9 Latin America Cervical Cancer Diagnostic Test Market, by Country/Region, 2016–2026 (US$ Mn)
TABLE 10 Asia Pacific Cervical Cancer Diagnostic Test Market, by Diagnostic Test Type, 2016–2026 (US$ Mn)
TABLE 11 Asia Pacific Cervical Cancer Diagnostic Test Market, by Diagnostic Test Type, 2016–2026 (US$ Mn)
TABLE 12 Asia Pacific Cervical Cancer Diagnostic Test Market, by Country/Region, 2016–2026 (US$ Mn)
TABLE 13 Middle East & Africa Cervical Cancer Diagnostic Test Market, by Diagnostic Test Type, 2016–2026 (US$ Mn)
TABLE 14 Middle East & Africa Cervical Cancer Diagnostic Test Market, by Region, 2016–2026 (US$ Mn)
TABLE 15 Hologic Corporation.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 16 Becton, Dickinson and Company: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 17 Qiagen N.V.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 18 Siemens Healthcare: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 19 Guided Therapeutics Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 20 Ascon Medical Instruments Pvt Ltd: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 21 Hoffmann-La Roche.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 22 Cooper Surgical Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 23 Cardinal Health, Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 24 Beckman Coulter Inc. Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)

Choose License Type
Connect With Us
+1-800-361-8290
24/7 Research Support

Credence Webinars

Join Credence analysts to explore the latest IT Trends

view upcoming webinars

Our Clients